The present invention relates to topical pharmaceutical compositions of apremilast used for the treatment of psoriasis and/or psoriatic arthritis. It further relates to processes of preparation of the compositions and the method of use for these compositions.

Abstract The present invention relates to topical compositions comprising apremilast. It also relates to processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatosis, eczema, rosacea, acne vulgaris, allergies, contact and atopic dermat...

The present invention provides a topical composition of Apremilast with lipohilic agents. The plurality of excipients each present in amounts, and in combination, to effectively control the release of Apremilast from the composition for better penetration in to the skin. The present invention also provides a process...

The present invention relates to a novel topical pharmaceutical composition of Teriflunomide, methods of preparing such compositions for long term storage stability, and use thereof for relieving the symptoms of pain and arthritis in subjects suffering from autoimmune diseases like multiple sclerosis or rheumatoid a...

ABSTRACT STABLE AMORPHOUS ELIGLUSTAT PREMIX AND PROCESS FOR THE PREPARATION THEREOF The present invention relates to pharmaceutical compositions of Eliglustat. In particular the present invention relates to stable amorphous Eliglustat premix, method of preparation of the same and pharmaceutical compositions ...

The present invention relates to simple and stable pharmaceutical compositions comprising an effective amount of Diclofenac. The present invention provides solidoral dosage forms containing Diclofenac or pharmaceutically acceptable salts or derivatives thereof in a relatively low dose; and simple and inexpensive met...

The present invention provides a low dose topical composition of Apremilast with pharmaceutically acceptable excipients. The present invention also relates to a topical clear gel composition of apremilast for delivering a desired therapeutic amount of drug to the site of action after topical application. The present...

ABSTRACT IMPROVED AND STABLE APREMILAST PHARMACEUTICAL COMPOSITIONS The present invention relates to an improved and stable topical pharmaceutical compositions of apremilast used for the treatment of psoriasis and/or psoriatic arthritis. It further relates to processes of preparation of the stable compositions ...